EditorialEditorial
Compositional Magnetic Resonance Imaging Measures of Cartilage — Endpoints for Clinical Trials of Disease-modifying Osteoarthritis Drugs?
ALI GUERMAZI, MICHEL D. CREMA and FRANK W. ROEMER
The Journal of Rheumatology January 2016, 43 (1) 7-11; DOI: https://doi.org/10.3899/jrheum.150663
ALI GUERMAZI
Professor of Radiology, Director, Quantitative Imaging Center, Boston University School of Medicine, Boston, Massachusetts;
MD, PhDMICHEL D. CREMA
Department of Radiology, Boston University School of Medicine, Boston, Massachusetts,
USA, and Department of Radiology, Hospital do Coração and Teleimagem, São Paulo,
Brazil;
MDFRANK W. ROEMER
Department of Radiology, Boston University School of Medicine, Boston, Massachusetts,
USA, and Department of Radiology, University of Erlangen, Erlangen,
Germany.
MDREFERENCES
- 1.↵
- 2.↵
- McAlindon TE,
- Nuite M,
- Krishnan N,
- Ruthazer R,
- Price LL,
- Burstein D,
- et al.
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- Liebl H,
- Joseph G,
- Nevitt MC,
- Singh N,
- Heilmeier U,
- Subburaj K,
- et al.
- 7.↵
- 8.↵
- 9.↵
- 10.↵
- 11.↵
- 12.↵
- Crema MD,
- Hunter DJ,
- Burstein D,
- Roemer FW,
- Krishnan N,
- Hellio Le Graverand MP,
- et al.
- 13.↵
- Owman H,
- Ericsson YB,
- Englund M,
- Tiderius CJ,
- Tjörnstrand J,
- Roos EM,
- et al.
- 14.↵
- Crema MD,
- Hunter DJ,
- Burstein D,
- Roemer FW,
- Li L,
- Krishnan N,
- et al.
- 15.↵
- Crema MD,
- Hunter DJ,
- Burstein D,
- Roemer FW,
- Li L,
- Eckstein F,
- et al.
- 16.↵
- van Tiel J,
- Kotek G,
- Reijman M,
- Bos PK,
- Bron EE,
- Klein S,
- et al.
- 17.↵
- 18.↵
- 19.↵
- 20.↵
- Ling W,
- Regatte RR,
- Navon G,
- Jerschow A
- 21.↵
In this issue
The Journal of Rheumatology
Vol. 43, Issue 1
1 Jan 2016
Compositional Magnetic Resonance Imaging Measures of Cartilage — Endpoints for Clinical Trials of Disease-modifying Osteoarthritis Drugs?
ALI GUERMAZI, MICHEL D. CREMA, FRANK W. ROEMER
The Journal of Rheumatology Jan 2016, 43 (1) 7-11; DOI: 10.3899/jrheum.150663